机构:[1]Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The State & NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China[2]Department of Preventive Dentistry, Affiliated Stomatology Hospital of Guangzhou Medical University, Guangdong Engineering Research Center of Oral Restoration and Reconstruction, Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou, China[3]State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, AvenidaWailong, Taipa, Macau, China[4]Department of Ophthalmology, B5500 Clinic B, 1365B Clifton Road NE, Emory University, Atlanta, Georgia, USA[5]Department of Pharmaceutical Sciences, Institute for Biotechnology, College of Pharmacy and Health Sciences, St. John’s University, Queens, New York, USA
National Natural Science Foundation of
China, Grant/Award Numbers: 82000080,
82070406, 82104374; Guangzhou Science
and Technology Plan Project,
Grant/Award Number: 202102020073;
Guangzhou Higher Education Teaching
Quality and Teaching Reform
Project-Excellent Talent Training Program, Grant/Award Number:
2022ZXRCPR008; Guangdong Medical
Research Foundation, Grant/Award
Number: A2023261; Outstanding Youth
Development Program of Guangzhou
Medical University, Grant/Award
Number: 02-410-2302377XM; Peak
Discipline construction project of
Guangzhou Medical
University-Epigenetic Drug Development
Project, Grant/Award Numbers:
02-445-2301220XM, 02-445-2301164XM;
First-class professional construction
project of Guangzhou Medical University,
Grant/Award Number:
02-408-2304-13029XM
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
无
最新[2025]版:
大类|1 区医学
小类|1 区医学:研究与实验
第一作者:
第一作者机构:[1]Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The State & NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China
共同第一作者:
通讯作者:
通讯机构:[1]Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The State & NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China[5]Department of Pharmaceutical Sciences, Institute for Biotechnology, College of Pharmacy and Health Sciences, St. John’s University, Queens, New York, USA[*1]Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the State & NMPA Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou 511436, China.[*2]Department of Pharmaceutical Sciences, Institute for Biotechnology, College of Pharmacy and Health Sciences, St. John’s University, Queens, NY 11439, USA.
推荐引用方式(GB/T 7714):
Liang Lu,Xu Wenyan,Shen Ao,et al.Inhibition of YAP1 activity ameliorates acute lung injury through promotion of M2 macrophage polarization[J].MedComm.2023,4(3):e293.doi:10.1002/mco2.293.
APA:
Liang Lu,Xu Wenyan,Shen Ao,Fu Xiaomei,Cen Huiyu...&Yu Xiyong.(2023).Inhibition of YAP1 activity ameliorates acute lung injury through promotion of M2 macrophage polarization.MedComm,4,(3)
MLA:
Liang Lu,et al."Inhibition of YAP1 activity ameliorates acute lung injury through promotion of M2 macrophage polarization".MedComm 4..3(2023):e293